Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure AB (Ribo) today announced a collaboration with Boehringer Ingelheim to develop novel treatments...
/PRNewswire/ -- The Scleroderma Research Foundation (SRF), the nation's largest non-profit funder of scleroderma research, today announced that the FDA has...
Over 140 healthcare professionals from the Middle East and Africa gathered for the third edition of the Interstitial Lung Disease (ILD) Summit to discuss the latest developments in the treatment and management of respiratory conditions.
TORONTO & WALTHAM, Mass.--(BUSINESS WIRE)--Nov 29, 2023--
Boehringer Ingelheim and IBM announced an agreement that will enable Boehringer to use IBM’s foundation model technologies to discover novel candidate antibodies for the development of efficient therapeutics.